New USP Food Fraud Mitigation Guidance aims to help manufacturers and regulators identify ingredients most vulnerable to fraud in their supply chains and choose effective mitigation tools to combat economically-motivated adulteration.
October is Talk About Your Medicines Month. Sponsored by NCPIE, a USP Convention member organization, this annual opportunity encourages patients and healthcare providers to engage in conversation about medications and their safe use, safe storage, and safe disposal.
Pictograms, a free resource from USP, are simple illustrations that help ensure proper medication use for low-literacy and non-native language speaking patients. They provide healthcare professionals with a useful tool to overcome communication and comprehension issues that may arise.
Gigi Davidson, R.Ph., DICVP, Chair of USP's Compounding Expert Committee shares her thoughts and background information on proposed revisions to <797> Pharmaceutical Compounding—Sterile Preparations. Compounding practitioners are encouraged to view and share comments on the changes online.
Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field.
Anita Szajek, Ph.D., principal scientific liaison to USP’s Expert Panel on Therapeutic Peptides, examines therapeutic peptides, the transition from recombinant to synthetic manufacturing routes, and regulatory and quality-related questions.
Tainted “lifestyle supplements" may outnumber products free from drugs and their unapproved synthetic analogs. Learn how proposed new screening methods in USP General Chapter <2251> Adulteration of Dietary Supplements with Drugs and Drug Analogs can help detect these adulterants and protect public health.